Market Research Industry Reports

Generics Global Group of Eight (G8) Industry Guide 2017-2021

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Generics Global Group of Eight (G8) Industry Guide 2017-2021

Summary

The G8 Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Essential resource for top-line data and analysis covering the G8 generics market. Includes market size data, textual and graphical analysis of market growth trends and leading companies.

Key Highlights

- The G8 countries contributed $1,89,457.1 million in 2016 to the global generics industry, with a compound annual growth rate (CAGR) of 8.4% between 2012 and 2016. The G8 countries are expected to reach a value of $2,68,983.2 million in 2021, with a CAGR of 7.3% over the 2016-21 period.
- Among the G8 nations, the US is the leading country in the generics industry, with market revenues of $1,01,790.0 million in 2016. This was followed by Japan and Germany, with a value of $45,850.0 and $18,657.1 million, respectively.
- The US is expected to lead the generics industry in the G8 nations with a value of $1,48,130.6 million in 2016, followed by Japan and Germany with expected values of $62,926.8 and $22,373.1 million, respectively.

Scope

- Save time carrying out entry-level research by identifying the size, growth, and leading players in the G8 generics market
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the G8 generics market
- Leading company profiles reveal details of key generics market players G8 operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the G8 generics market with five year forecasts by both value and volume
- Compares data from the US, Canada, Germany, France, UK, Italy, Russia and Japan, alongside individual chapters on each country

Reasons to buy

- What was the size of the G8 generics market by value in 2016?
- What will be the size of the G8 generics market in 2021?
- What factors are affecting the strength of competition in the G8 generics market?
- How has the market performed over the last five years?
- How large is the G8 generics market in relation to its regional counterparts?

Introduction 14
What is this report about? 14
Who is the target reader? 14
How to use this report 14
Definitions 14
Group of Eight (G8) Generics 15
Industry Outlook 15
Generics in Canada 19
Market Overview 19
Market Data 20
Market Segmentation 22
Market outlook 23
Five forces analysis 25
Macroeconomic indicators 31
Generics in France 33
Market Overview 33
Market Data 34
Market Segmentation 36
Market outlook 37
Five forces analysis 39
Macroeconomic indicators 45
Generics in Germany 47
Market Overview 47
Market Data 48
Market Segmentation 50
Market outlook 51
Five forces analysis 53
Macroeconomic indicators 59
Generics in Italy 61
Market Overview 61
Market Data 62
Market Segmentation 64
Market outlook 65
Five forces analysis 67
Macroeconomic indicators 73
Generics in Japan 75
Market Overview 75
Market Data 76
Market Segmentation 78
Market outlook 79
Five forces analysis 81
Macroeconomic indicators 87
Generics in Russia 89
Market Overview 89
Market Data 90
Market Segmentation 92
Market outlook 93
Five forces analysis 95
Macroeconomic indicators 101
Generics in The United Kingdom 103
Market Overview 103
Market Data 104
Market Segmentation 106
Market outlook 107
Five forces analysis 109
Macroeconomic indicators 115
Generics in The United States 117
Market Overview 117
Market Data 118
Market Segmentation 120
Market outlook 121
Five forces analysis 123
Macroeconomic indicators 129
Company Profiles 131
Leading Companies 131
Appendix 161
Methodology 161
About MarketLine 162

List Of Tables

List of Tables
Table 1: G8 generics industry, revenue($m), 2012-21
Table 2: G8 generics industry, revenue by country ($m), 2012-16
Table 3: G8 generics industry forecast, revenue by country ($m), 2016-21
Table 4: Canada generics market value: $ million, 2012-16
Table 5: Canada generics market volume: % of total pharma volume, 2012-16
Table 6: Canada generics market geography segmentation: $ million, 2016
Table 7: Canada generics market value forecast: $ million, 2016-21
Table 8: Canada generics market volume forecast: % of total pharma volume, 2016-21
Table 87: Canada size of population (million), 2012-16
Table 88: Canada gdp (constant 2005 prices, $ billion), 2012-16
Table 89: Canada gdp (current prices, $ billion), 2012-16
Table 90: Canada inflation, 2012-16
Table 91: Canada consumer price index (absolute), 2012-16
Table 92: Canada exchange rate, 2012-16
Table 9: France generics market value: $ million, 2012-16
Table 10: France generics market volume: % of total pharma volume, 2012-16
Table 11: France generics market geography segmentation: $ million, 2016
Table 12: France generics market value forecast: $ million, 2016-21
Table 13: France generics market volume forecast: % of total pharma volume, 2016-21
Table 14: France size of population (million), 2012-16
Table 15: France gdp (constant 2005 prices, $ billion), 2012-16
Table 16: France gdp (current prices, $ billion), 2012-16
Table 17: France inflation, 2012-16
Table 18: France consumer price index (absolute), 2012-16
Table 19: France exchange rate, 2012-16
Table 20: Germany generics market value: $ million, 2012-16
Table 21: Germany generics market volume: % of total pharma volume, 2012-16
Table 22: Germany generics market geography segmentation: $ million, 2016
Table 23: Germany generics market value forecast: $ million, 2016-21
Table 24: Germany generics market volume forecast: % of total pharma volume, 2016-21
Table 25: Germany size of population (million), 2012-16
Table 26: Germany gdp (constant 2005 prices, $ billion), 2012-16
Table 27: Germany gdp (current prices, $ billion), 2012-16
Table 28: Germany inflation, 2012-16
Table 29: Germany consumer price index (absolute), 2012-16
Table 30: Germany exchange rate, 2012-16
Table 31: Italy generics market value: $ million, 2012-16
Table 32: Italy generics market volume: % of total pharma volume, 2012-16
Table 33: Italy generics market geography segmentation: $ million, 2016
Table 34: Italy generics market value forecast: $ million, 2016-21
Table 35: Italy generics market volume forecast: % of total pharma volume, 2016-21
Table 36: Italy size of population (million), 2012-16
Table 37: Italy gdp (constant 2005 prices, $ billion), 2012-16
Table 38: Italy gdp (current prices, $ billion), 2012-16
Table 39: Italy inflation, 2012-16
Table 40: Italy consumer price index (absolute), 2012-16
Table 41: Italy exchange rate, 2012-16
Table 42: Japan generics market value: $ billion, 2012-16
Table 43: Japan generics market volume: % of total pharma volume, 2012-16
Table 44: Japan generics market geography segmentation: $ billion, 2016
Table 45: Japan generics market value forecast: $ billion, 2016-21
Table 46: Japan generics market volume forecast: % of total pharma volume, 2016-21
Table 47: Japan size of population (million), 2012-16
Table 48: Japan gdp (constant 2005 prices, $ billion), 2012-16
Table 49: Japan gdp (current prices, $ billion), 2012-16
Table 50: Japan inflation, 2012-16
Table 51: Japan consumer price index (absolute), 2012-16
Table 52: Japan exchange rate, 2012-16
Table 53: Russia generics market value: $ million, 2012-16
Table 54: Russia generics market volume: % of total pharma volume, 2012-16
Table 55: Russia generics market geography segmentation: $ million, 2016
Table 56: Russia generics market value forecast: $ million, 2016-21
Table 57: Russia generics market volume forecast: % of total pharma volume, 2016-21
Table 58: Russia size of population (million), 2012-16
Table 59: Russia gdp (constant 2005 prices, $ billion), 2012-16
Table 60: Russia gdp (current prices, $ billion), 2012-16
Table 61: Russia inflation, 2012-16
Table 62: Russia consumer price index (absolute), 2012-16
Table 63: Russia exchange rate, 2012-16
Table 64: United Kingdom generics market value: $ million, 2012-16
Table 65: United Kingdom generics market volume: % of total pharma volume, 2012-16
Table 66: United Kingdom generics market geography segmentation: $ million, 2016
Table 67: United Kingdom generics market value forecast: $ million, 2016-21
Table 68: United Kingdom generics market volume forecast: % of total pharma volume, 2016-21
Table 69: United Kingdom size of population (million), 2012-16
Table 70: United Kingdom gdp (constant 2005 prices, $ billion), 2012-16
Table 71: United Kingdom gdp (current prices, $ billion), 2012-16
Table 72: United Kingdom inflation, 2012-16
Table 73: United Kingdom consumer price index (absolute), 2012-16
Table 74: United Kingdom exchange rate, 2012-16
Table 75: United States generics market value: $ billion, 2012-16
Table 76: United States generics market volume: % of total pharma volume, 2012-16
Table 77: United States generics market geography segmentation: $ billion, 2016
Table 78: United States generics market value forecast: $ billion, 2016-21
Table 79: United States generics market volume forecast: % of total pharma volume, 2016-21
Table 80: United States size of population (million), 2012-16
Table 81: United States gdp (constant 2005 prices, $ billion), 2012-16
Table 82: United States gdp (current prices, $ billion), 2012-16
Table 83: United States inflation, 2012-16
Table 84: United States consumer price index (absolute), 2012-16
Table 85: United States exchange rate, 2012-15
Table 86: Apotex, Inc.: key facts
Table 93: Les Laboratoires Servier: key facts
Table 94: STADA Arzneimittel AG: key facts
Table 95: STADA Arzneimittel AG: key financials ($)
Table 96: STADA Arzneimittel AG: key financials ()
Table 97: STADA Arzneimittel AG: key financial ratios
Table 98: Sanofi SA: key facts
Table 99: Sanofi SA: key financials ($)
Table 100: Sanofi SA: key financials ()
Table 101: Sanofi SA: key financial ratios
Table 102: Sawai Pharmaceutical Co., Ltd.: key facts
Table 103: Sawai Pharmaceutical Co., Ltd.: key financials ($)
Table 104: Sawai Pharmaceutical Co., Ltd.: key financials ()
Table 105: Sawai Pharmaceutical Co., Ltd.: key financial ratios
Table 106: Daiichi Sankyo Co., Ltd.: key facts
Table 107: Daiichi Sankyo Co., Ltd.: key financials ($)
Table 108: Daiichi Sankyo Co., Ltd.: key financials ()
Table 109: Daiichi Sankyo Co., Ltd.: key financial ratios
Table 110: Abbott Laboratories: key facts
Table 111: Abbott Laboratories: key financials ($)
Table 112: Abbott Laboratories: key financial ratios
Table 113: Krka, d. d., Novo mesto: key facts
Table 114: Krka, d. d., Novo mesto: key financials ($)
Table 115: Krka, d. d., Novo mesto: key financials ()
Table 116: Krka, d. d., Novo mesto: key financial ratios
Table 117: Mylan N.V.: key facts
Table 118: Mylan N.V.: key financials ($)
Table 119: Mylan N.V.: key financial ratios
Table 120: Novartis AG: key facts
Table 121: Novartis AG: key financials ($)
Table 122: Novartis AG: key financial ratios
Table 123: Teva Pharmaceutical Industries Limited: key facts
Table 124: Teva Pharmaceutical Industries Limited: key financials ($)
Table 125: Teva Pharmaceutical Industries Limited: key financial ratios

List Of Figures

List of Figures
Figure 1: G8 generics industry, revenue($m), 2012-21
Figure 2: G8 Generics industry, revenue by country (%), 2016
Figure 3: G8 generics industry, revenue by country ($m), 2012-16
Figure 4: G8 generics industry forecast, revenue by country ($m), 2016-21
Figure 5: Canada generics market value: $ million, 2012-16
Figure 6: Canada generics market volume: % of total pharma volume, 2012-16
Figure 7: Canada generics market geography segmentation: % share, by value, 2016
Figure 8: Canada generics market value forecast: $ million, 2016-21
Figure 9: Canada generics market volume forecast: % of total pharma volume, 2016-21
Figure 10: Forces driving competition in the generics market in Canada, 2016
Figure 11: Drivers of buyer power in the generics market in Canada, 2016
Figure 12: Drivers of supplier power in the generics market in Canada, 2016
Figure 13: Factors influencing the likelihood of new entrants in the generics market in Canada, 2016
Figure 14: Factors influencing the threat of substitutes in the generics market in Canada, 2016
Figure 15: Drivers of degree of rivalry in the generics market in Canada, 2016
Figure 16: France generics market value: $ million, 2012-16
Figure 17: France generics market volume: % of total pharma volume, 2012-16
Figure 18: France generics market geography segmentation: % share, by value, 2016
Figure 19: France generics market value forecast: $ million, 2016-21
Figure 20: France generics market volume forecast: % of total pharma volume, 2016-21
Figure 21: Forces driving competition in the generics market in France, 2016
Figure 22: Drivers of buyer power in the generics market in France, 2016
Figure 23: Drivers of supplier power in the generics market in France, 2016
Figure 24: Factors influencing the likelihood of new entrants in the generics market in France, 2016
Figure 25: Factors influencing the threat of substitutes in the generics market in France, 2016
Figure 26: Drivers of degree of rivalry in the generics market in France, 2016
Figure 27: Germany generics market value: $ million, 2012-16
Figure 28: Germany generics market volume: % of total pharma volume, 2012-16
Figure 29: Germany generics market geography segmentation: % share, by value, 2016
Figure 30: Germany generics market value forecast: $ million, 2016-21
Figure 31: Germany generics market volume forecast: % of total pharma volume, 2016-21
Figure 32: Forces driving competition in the generics market in Germany, 2016
Figure 33: Drivers of buyer power in the generics market in Germany, 2016
Figure 34: Drivers of supplier power in the generics market in Germany, 2016
Figure 35: Factors influencing the likelihood of new entrants in the generics market in Germany, 2016
Figure 36: Factors influencing the threat of substitutes in the generics market in Germany, 2016
Figure 37: Drivers of degree of rivalry in the generics market in Germany, 2016
Figure 38: Italy generics market value: $ million, 2012-16
Figure 39: Italy generics market volume: % of total pharma volume, 2012-16
Figure 40: Italy generics market geography segmentation: % share, by value, 2016
Figure 41: Italy generics market value forecast: $ million, 2016-21
Figure 42: Italy generics market volume forecast: % of total pharma volume, 2016-21
Figure 43: Forces driving competition in the generics market in Italy, 2016
Figure 44: Drivers of buyer power in the generics market in Italy, 2016
Figure 45: Drivers of supplier power in the generics market in Italy, 2016
Figure 46: Factors influencing the likelihood of new entrants in the generics market in Italy, 2016
Figure 47: Factors influencing the threat of substitutes in the generics market in Italy, 2016
Figure 48: Drivers of degree of rivalry in the generics market in Italy, 2016
Figure 49: Japan generics market value: $ billion, 2012-16
Figure 50: Japan generics market volume: % of total pharma volume, 2012-16
Figure 51: Japan generics market geography segmentation: % share, by value, 2016
Figure 52: Japan generics market value forecast: $ billion, 2016-21
Figure 53: Japan generics market volume forecast: % of total pharma volume, 2016-21
Figure 54: Forces driving competition in the generics market in Japan, 2016
Figure 55: Drivers of buyer power in the generics market in Japan, 2016
Figure 56: Drivers of supplier power in the generics market in Japan, 2016
Figure 57: Factors influencing the likelihood of new entrants in the generics market in Japan, 2016
Figure 58: Factors influencing the threat of substitutes in the generics market in Japan, 2016
Figure 59: Drivers of degree of rivalry in the generics market in Japan, 2016
Figure 60: Russia generics market value: $ million, 2012-16
Figure 61: Russia generics market volume: % of total pharma volume, 2012-16
Figure 62: Russia generics market geography segmentation: % share, by value, 2016
Figure 63: Russia generics market value forecast: $ million, 2016-21
Figure 64: Russia generics market volume forecast: % of total pharma volume, 2016-21
Figure 65: Forces driving competition in the generics market in Russia, 2016
Figure 66: Drivers of buyer power in the generics market in Russia, 2016
Figure 67: Drivers of supplier power in the generics market in Russia, 2016
Figure 68: Factors influencing the likelihood of new entrants in the generics market in Russia, 2016
Figure 69: Factors influencing the threat of substitutes in the generics market in Russia, 2016
Figure 70: Drivers of degree of rivalry in the generics market in Russia, 2016
Figure 71: United Kingdom generics market value: $ million, 2012-16
Figure 72: United Kingdom generics market volume: % of total pharma volume, 2012-16
Figure 73: United Kingdom generics market geography segmentation: % share, by value, 2016
Figure 74: United Kingdom generics market value forecast: $ million, 2016-21
Figure 75: United Kingdom generics market volume forecast: % of total pharma volume, 2016-21
Figure 76: Forces driving competition in the generics market in the United Kingdom, 2016
Figure 77: Drivers of buyer power in the generics market in the United Kingdom, 2016
Figure 78: Drivers of supplier power in the generics market in the United Kingdom, 2016
Figure 79: Factors influencing the likelihood of new entrants in the generics market in the United Kingdom, 2016
Figure 80: Factors influencing the threat of substitutes in the generics market in the United Kingdom, 2016
Figure 81: Drivers of degree of rivalry in the generics market in the United Kingdom, 2016
Figure 82: United States generics market value: $ billion, 2012-16
Figure 83: United States generics market volume: % of total pharma volume, 2012-16
Figure 84: United States generics market geography segmentation: % share, by value, 2016
Figure 85: United States generics market value forecast: $ billion, 2016-21
Figure 86: United States generics market volume forecast: % of total pharma volume, 2016-21
Figure 87: Forces driving competition in the generics market in the United States, 2016
Figure 88: Drivers of buyer power in the generics market in the United States, 2016
Figure 89: Drivers of supplier power in the generics market in the United States, 2016
Figure 90: Factors influencing the likelihood of new entrants in the generics market in the United States, 2016
Figure 91: Factors influencing the threat of substitutes in the generics market in the United States, 2016
Figure 92: Drivers of degree of rivalry in the generics market in the United States, 2016
Figure 93: STADA Arzneimittel AG: revenues & profitability
Figure 94: STADA Arzneimittel AG: assets & liabilities
Figure 95: Sanofi SA: revenues & profitability
Figure 96: Sanofi SA: assets & liabilities
Figure 97: Sawai Pharmaceutical Co., Ltd.: revenues & profitability
Figure 98: Sawai Pharmaceutical Co., Ltd.: assets & liabilities
Figure 99: Daiichi Sankyo Co., Ltd.: revenues & profitability
Figure 100: Daiichi Sankyo Co., Ltd.: assets & liabilities
Figure 101: Abbott Laboratories: revenues & profitability
Figure 102: Abbott Laboratories: assets & liabilities
Figure 103: Krka, d. d., Novo mesto: revenues & profitability
Figure 104: Krka, d. d., Novo mesto: assets & liabilities
Figure 105: Mylan N.V.: revenues & profitability
Figure 106: Mylan N.V.: assets & liabilities
Figure 107: Novartis AG: revenues & profitability
Figure 108: Novartis AG: assets & liabilities
Figure 109: Teva Pharmaceutical Industries Limited: revenues & profitability
Figure 110: Teva Pharmaceutical Industries Limited: assets & liabilities

Global Generics Industry Profile & Value Chain Analysis

Global Generics Industry Profile & Value Chain AnalysisGlobal Generics industry profile provides top-line qualitative and quantitative information including: market size (value and volume 2012-16, and forecast to 2021). The

USD 495View Report

Generics Global Industry Guide 2017-2021

Generics Global Industry Guide 2017-2021Global Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2012-16, and forecast to 2021). The profile also contains

USD 1495View Report

Confectionery Global Group of Eight (G8) Industry Guide 2013-2022

Confectionery Global Group of Eight (G8) Industry Guide 2013-2022The G8 Confectionery industry profile provides top-line qualitative and quantitative information including: market share, market size (value and volume 2013-17, and

USD 1495View Report

Breakfast Cereals Global Group of Eight (G8) Industry Guide 2013-2022

Breakfast Cereals Global Group of Eight (G8) Industry Guide 2013-2022The G8 Breakfast Cereals industry profile provides top-line qualitative and quantitative information including: market share, market size (value and volume

USD 1495View Report

Your are not allow to send sample request
Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 1495
  • Site Licence    USD 2990
  • Enterprise Wide Licence    USD 4485
$ 1495

Reports Details

Published Date : Feb 2018
No. of Pages :163
Country :G8
Category :Pharmaceuticals and Healthcare
Publisher :MarketLine
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube